Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Entertainment Wire Massachusetts.
Press releases published on May 28, 2025
CannabisNewsWire is the Official NewsWire sponsor of CMB
GlobeNewswire
·
May 28, 2025
AUSTIN, Texas, May 28, 2025 (GLOBE NEWSWIRE) -- CannabisNewsWire (CNW), a leading communications platform for the cannabis industry and part of the InvestorBrandNetwork (IBN), is thrilled to announce its engagement as the official newswire for Cannabis …
Immerse Yourself in The Phoenician Scheme x Angelika Experience
GlobeNewswire
·
May 28, 2025
NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- The Angelika Film Center …
Koddi Expands Capabilities to Power In-Store Media Activations with In-Store Marketplace Partnership
GlobeNewswire
·
May 28, 2025
FORT WORTH, Texas, May 28, 2025 (GLOBE NEWSWIRE) -- Koddi, the leading retail and commerce media technology for enterprises, and In-Store Marketplace announced a partnership to expand capabilities to broaden retailers’s networks in-store. Through a direct …
PRIDE Industries Honored with Second Gold STEVIE® Award in 2025 American Business Awards®
GlobeNewswire
·
May 28, 2025
Roseville, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- PRIDE Industries, the nation’s leading employer of people with disabilities, was named the winner of a Gold Stevie® Award in the “Video Awards - Diversity …
Kevin L. Hagan with PAN Foundation Discusses The Hidden Health Crisis: When Treatment Costs Break the Bank with YOURUPDATETV
GlobeNewswire
·
May 28, 2025
NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- We often hear that healthcare is personal—but for millions of Americans, it’s also financially devastating. New research from the PAN Foundation’s Center for Patient Research reveals a quiet crisis with massive …
Flare Therapeutics to Participate in Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, today announced that the …
IBN Initiates Coverage of Lahontan Gold Corp.
GlobeNewswire
·
May 28, 2025
AUSTIN, Texas, May 28, 2025 (GLOBE NEWSWIRE) -- via IBN – Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF), a Canadian mine development and exploration company, has selected IBN, a multifaceted financial news and publishing company serving private and public …
Ernexa Therapeutics Announces New Data to be Presented at ASCO Annual Meeting 2025
GlobeNewswire
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced that new data will be presented at the American Society …
iTeos Therapeutics Announces Its Intention to Wind Down Operations
GlobeNewswire
·
May 28, 2025
- Board of Directors intends to cease operations - Company to focus efforts on selecting best path to deliver near-term value to shareholders - Exploring potential asset sales including EOS-984, EOS-215, and a preclinical obesity program targeting ENT1 …
Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for CAN-2409 for the Treatment of Prostate Cancer
GlobeNewswire
·
May 28, 2025
NEEDHAM, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …
Liberty to Participate in Lytham Partners Investor Conference
GlobeNewswire
·
May 28, 2025
WILMINGTON, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (TSXV: SCAN, OTCQB: LDDFF, FSE:E30), a leading technology provider of AI-based next generation detection solutions for concealed weapons and …
ABLi Therapeutics Strengthens Leadership Team and Board of Directors
GlobeNewswire
·
May 28, 2025
Directors Appointed from Senior Leadership Teams of J…
Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer
GlobeNewswire
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced the appointment of …
Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
BOSTON, May 28, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today announced that the Company will participate in a …
Solid Biosciences to Participate at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
CHARLESTOWN, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, announced that Bo Cumbo, President …
Agios to Present at Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025
GlobeNewswire
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced that its management team is scheduled …
Verve Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 28, 2025
BOSTON , May 28, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that management will participate in fireside chats during the following investor …
Entrada Therapeutics Receives Authorization in the European Union to Initiate ELEVATE-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-45 in Patients Living with Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping
GlobeNewswire
·
May 28, 2025
– Company on track to begin ELEVATE-45-201 in Q3 2025 – – Follows recently received Medicines and Healthcare Products Regulatory Agency authorization in the United Kingdom for ELEVATE-45-201 – BOSTON, May 28, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, …
Triple Hair Group renforce son équipe de direction avec la nomination de Paul Sowyrda à son conseil d'administration
GlobeNewswire
·
May 28, 2025
MONTRÉAL, 28 mai 2025 (GLOBE NEWSWIRE) -- Triple Hair Group Inc. (« Triple Hair » ou la « Société »), une société spécialisée dans le développement de traitements novateurs contre l'alopécie androgénique, est heureuse d'annoncer la nomination de Paul …
Monte Rosa Therapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
BOSTON, May 28, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that Markus Warmuth, M.D., Chief Executive Officer …